The Chemours Company (NYSE:CC - Get Free Report)'s stock price hit a new 52-week low on Monday . The stock traded as low as $14.54 and last traded at $14.54, with a volume of 698686 shares traded. The stock had previously closed at $14.95.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on CC shares. Morgan Stanley reduced their target price on shares of Chemours from $25.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Monday, January 13th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $25.00 price objective on shares of Chemours in a research note on Thursday, December 12th. Barclays lowered their target price on shares of Chemours from $23.00 to $19.00 and set an "equal weight" rating for the company in a report on Monday, February 24th. BMO Capital Markets cut their price target on Chemours from $34.00 to $27.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 19th. Finally, Mizuho decreased their price objective on Chemours from $22.00 to $21.00 and set a "neutral" rating for the company in a research note on Tuesday, January 7th. Five research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $23.11.
Read Our Latest Stock Analysis on Chemours
Chemours Price Performance
The company has a 50 day moving average of $17.70 and a 200 day moving average of $18.76. The company has a current ratio of 1.68, a quick ratio of 0.92 and a debt-to-equity ratio of 6.70. The firm has a market cap of $2.11 billion, a price-to-earnings ratio of 24.76 and a beta of 1.81.
Chemours (NYSE:CC - Get Free Report) last released its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of $0.10 by $0.01. Chemours had a return on equity of 26.54% and a net margin of 1.51%. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. Equities research analysts predict that The Chemours Company will post 2.03 EPS for the current fiscal year.
Chemours Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 28th will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 7.08%. The ex-dividend date of this dividend is Friday, February 28th. Chemours's dividend payout ratio (DPR) is presently 175.44%.
Institutional Investors Weigh In On Chemours
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Norges Bank bought a new position in Chemours during the 4th quarter worth about $30,702,000. Appian Way Asset Management LP acquired a new position in shares of Chemours during the third quarter worth about $34,151,000. Vision One Management Partners LP bought a new position in shares of Chemours during the third quarter worth about $28,252,000. Bank of Montreal Can raised its position in Chemours by 1,496.4% in the 4th quarter. Bank of Montreal Can now owns 953,240 shares of the specialty chemicals company's stock valued at $16,110,000 after buying an additional 893,530 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its position in Chemours by 23.8% in the 4th quarter. Ameriprise Financial Inc. now owns 4,373,172 shares of the specialty chemicals company's stock valued at $73,907,000 after buying an additional 839,849 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.
About Chemours
(
Get Free Report)
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Further Reading
Before you consider Chemours, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemours wasn't on the list.
While Chemours currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
